J. Mazza-Stalder

Discipline

Sciences de l'information et de la communication (1) Anthropologie biologique (1)

Type de document

Articles (10) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Tuberculosis (9) Tuberculosis (9) Diagnosis (7) Patients (7) Diagnosis (7) Patients (7) Human beings (6) Specimens (5) Specimens (5) Performance (5) Mycobacterium tuberculosis (5) Mycobacterium (5) Performance (5) temps (durée) (4) épuration (4) microscopie (4) Microscopy (4) Time (4) Examinations (4) Culture (4) Purification (4) Microscopy (4) test (3) investigation (3) analyse (3) adulte (3) abords (agglomération) (3) Lausanne (3) Value added (3) Drug resistance (3)

Documents écrit par J. Mazza-Stalder (10) | parle de J. Mazza-Stalder (0)

Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
M.O. Boldi et al. (2023)
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
S. Laurent et al.
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
M. Tadolini et al.
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection.
O. Opota et al.
Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
S. Andenmatten et al.
Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities.
F. Zakham et al.
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
O. Opota et al.
Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach.
J. Mazza-Stalder et al. (2019)
Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
O. Opota et al.
Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
V. Rozot et al. (2015)